Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies.
Saved in:
| Title: | Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies. |
|---|---|
| Authors: | Khera N; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA., Edwards ML; Analysis Group Inc., New York, NY, USA., Song Y; Analysis Group Inc., Boston, MA, USA., Sun R; Analysis Group Inc., Boston, MA, USA., Manghani R; Gamida Cell Inc., Boston, MA, USA., Shin H; Gamida Cell Inc., Boston, MA, USA., Simantov R; Gamida Cell Inc., Boston, MA, USA., Signorovitch J; Analysis Group Inc., Boston, MA, USA., Sivaraman S; Gamida Cell Inc., Boston, MA, USA., Gergis U; Department of Medical Oncology, Thomas Jefferson University, 834 Chestnut St, Ste 308, Philadelphia, PA, 19107, USA. usama.gergis@jefferson.edu. |
| Source: | Advances in therapy [Adv Ther] 2024 Apr; Vol. 41 (4), pp. 1637-1651. Date of Electronic Publication: 2024 Mar 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38427220 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Khera+N%22">Khera N</searchLink>; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Edwards+ML%22">Edwards ML</searchLink>; Analysis Group Inc., New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Song+Y%22">Song Y</searchLink>; Analysis Group Inc., Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sun+R%22">Sun R</searchLink>; Analysis Group Inc., Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Manghani+R%22">Manghani R</searchLink>; Gamida Cell Inc., Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Shin+H%22">Shin H</searchLink>; Gamida Cell Inc., Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Simantov+R%22">Simantov R</searchLink>; Gamida Cell Inc., Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Signorovitch+J%22">Signorovitch J</searchLink>; Analysis Group Inc., Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sivaraman+S%22">Sivaraman S</searchLink>; Gamida Cell Inc., Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Gergis+U%22">Gergis U</searchLink>; Department of Medical Oncology, Thomas Jefferson University, 834 Chestnut St, Ste 308, Philadelphia, PA, 19107, USA. usama.gergis@jefferson.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228611864%22">Advances in therapy</searchLink> [Adv Ther] 2024 Apr; Vol. 41 (4), pp. 1637-1651. <i>Date of Electronic Publication: </i>2024 Mar 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Health+Communications+Inc%22">Health Communications Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8611864 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220741238X%22">0741238X </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38427220 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s12325-023-02771-z Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1637 Titles: – TitleFull: Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Khera N – PersonEntity: Name: NameFull: Edwards ML – PersonEntity: Name: NameFull: Song Y – PersonEntity: Name: NameFull: Sun R – PersonEntity: Name: NameFull: Manghani R – PersonEntity: Name: NameFull: Shin H – PersonEntity: Name: NameFull: Simantov R – PersonEntity: Name: NameFull: Signorovitch J – PersonEntity: Name: NameFull: Sivaraman S – PersonEntity: Name: NameFull: Gergis U IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2024 Apr Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1865-8652 Numbering: – Type: volume Value: 41 – Type: issue Value: 4 Titles: – TitleFull: Advances in therapy Type: main |
| ResultId | 1 |